-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS ANNOUNCES FDA IND CLEARANCE ENABLING ACCELERATION OF PRIVOSEGTOR DEVELOPMENT PROGRAM IN ACUTE MULTIPLE SCLEROSIS RELAPSES

Reuters·11/16/2026 07:00:00

Please log in to view news